We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Name | Symbol | Market | Type |
|---|---|---|---|
| GSK plc | NYSE:GSK | NYSE | Depository Receipt |
| Price Change | % Change | Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|
| 0.34 | 0.82% | 41.95 | 5,125 | 09:38:10 |
From Apr 2019 to Apr 2024
LONDON—GlaxoSmithKline PLC on Tuesday named Emma Walmsley as chief executive officer designate to take over from Andrew Witty when he retires next year.
In March, the pharmaceutical giant said Mr. Witty would retire as chief executive in March 2017, after a career at the company spanning more than 30 years and almost 10 years as its chief executive.
Ms. Walmsley, who is currently chief executive officer of GlaxoSmithKline's Consumer Healthcare division, will join the company's board of directors from January 2017.
Ms. Walmsley joined GlaxoSmithKline in 2010 from L'Oré al.
The company said its remuneration policy is currently under review and the remuneration committee will begin consultations with shareholders in the fourth quarter of 2016.
Write to Razak Musah Baba at Razak.Baba@wsj.com
(END) Dow Jones Newswires
September 20, 2016 03:25 ET (07:25 GMT)
Copyright (c) 2016 Dow Jones & Company, Inc.
1 Year GSK Chart |
1 Month GSK Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
